nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achieving and maintaining quality in the laboratory
|
HERTZBERG, M. S. |
|
2006 |
|
s3 |
p. 61-67 |
artikel |
2 |
Arthroscopic synovectomy in haemophilia: indications, technique and results
|
VERMA, N. |
|
2007 |
|
s3 |
p. 38-44 |
artikel |
3 |
Cellular and genetic therapies for haemophilia
|
LILLICRAP, D. |
|
2006 |
|
s3 |
p. 36-41 |
artikel |
4 |
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment
|
HAYWARD, C. P. M. |
|
2006 |
|
s3 |
p. 128-136 |
artikel |
5 |
Current understanding of von Willebrand's disease in women – some answers, more questions
|
KOUIDES, P. A. |
|
2006 |
|
s3 |
p. 143-151 |
artikel |
6 |
Diagnosis of haemophilic synovitis
|
GODDARD, N. J. |
|
2007 |
|
s3 |
p. 14-19 |
artikel |
7 |
Ethical issues in haemophilia
|
DIMICHELE, D. |
|
2006 |
|
s3 |
p. 30-35 |
artikel |
8 |
Genetic diagnosis of haemophilia and other inherited bleeding disorders
|
PEYVANDI, F. |
|
2006 |
|
s3 |
p. 82-89 |
artikel |
9 |
Haemophilia and ageing
|
STREET, A. |
|
2006 |
|
s3 |
p. 8-12 |
artikel |
10 |
Haemophilic synovitis: basic concepts
|
RODRIGUEZ-MERCHAN, E. C. |
|
2007 |
|
s3 |
p. 1-3 |
artikel |
11 |
HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
|
RODRIGUEZ-MERCHAN, E. C. |
|
2006 |
|
s3 |
p. 90-101 |
artikel |
12 |
Laboratory issues in bleeding disorders
|
LILLICRAP, D. |
|
2006 |
|
s3 |
p. 68-75 |
artikel |
13 |
New approaches for measuring coagulation
|
BARROWCLIFFE, T. W. |
|
2006 |
|
s3 |
p. 76-81 |
artikel |
14 |
Pathogenesis of haemophilic arthropathy
|
ROOSENDAAL, G. |
|
2006 |
|
s3 |
p. 117-121 |
artikel |
15 |
Pathogenesis of haemophilic synovitis: clinical aspects
|
HOOTS, W. K. |
|
2007 |
|
s3 |
p. 4-9 |
artikel |
16 |
Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage
|
VALENTINO, L. A. |
|
2007 |
|
s3 |
p. 10-13 |
artikel |
17 |
Physiotherapy following elective orthopaedic procedures
|
DE KLEIJN, P. |
|
2006 |
|
s3 |
p. 108-112 |
artikel |
18 |
Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy
|
VAN DEN BERG, H. M. |
|
2006 |
|
s3 |
p. 159-168 |
artikel |
19 |
Prevention of haemophilic synovitis: prophylaxis
|
LEE, C. A. |
|
2007 |
|
s3 |
p. 20-25 |
artikel |
20 |
Prophylaxis and treatment of chronic synovitis in haemophilia patients with inhibitors
|
RODRIGUEZ-MERCHAN, E. C. |
|
2007 |
|
s3 |
p. 45-48 |
artikel |
21 |
Quality of life assessment in clinical practice in haemophilia treatment
|
GRINGERI, A. |
|
2006 |
|
s3 |
p. 22-29 |
artikel |
22 |
Radioactive synoviorthesis for the treatment of haemophilic synovitis
|
RODRIGUEZ-MERCHAN, E. C. |
|
2007 |
|
s3 |
p. 32-37 |
artikel |
23 |
Rare bleeding disorders
|
PEYVANDI, F. |
|
2006 |
|
s3 |
p. 137-142 |
artikel |
24 |
Recent developments in clinimetric instruments
|
BEETON, K. |
|
2006 |
|
s3 |
p. 102-107 |
artikel |
25 |
Rehabilitation of synovitis in patients with haemophilia
|
SEUSER, A. |
|
2007 |
|
s3 |
p. 26-31 |
artikel |
26 |
Strategies towards a longer acting factor VIII
|
SAENKO, E. L. |
|
2006 |
|
s3 |
p. 42-51 |
artikel |
27 |
The natural evolution of haemophilia care: developing and sustaining comprehensive care globally
|
EVATT, B. L. |
|
2006 |
|
s3 |
p. 13-21 |
artikel |
28 |
The pharmacokinetics of coagulation factors
|
LEE, M. |
|
2006 |
|
s3 |
p. 1-7 |
artikel |
29 |
Tissue engineering in musculoskeletal problems related to haemophilia
|
CAVIGLIA, H. |
|
2006 |
|
s3 |
p. 122-127 |
artikel |
30 |
Total joint arthroplasty: the final solution for knee and hip when synovitis could not be controlled
|
RODRIGUEZ-MERCHAN, E. C. |
|
2007 |
|
s3 |
p. 49-58 |
artikel |
31 |
Total joint replacement in patients with inhibitors
|
SOLIMENO, L. P. |
|
2006 |
|
s3 |
p. 113-116 |
artikel |
32 |
Treatment for all: a vision for the future
|
SKINNER, M. W. |
|
2006 |
|
s3 |
p. 169-173 |
artikel |
33 |
Von Willebrand's disease: clinical management
|
FEDERICI, A. B. |
|
2006 |
|
s3 |
p. 152-158 |
artikel |
34 |
Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia
|
ASTERMARK, J. |
|
2006 |
|
s3 |
p. 52-60 |
artikel |